Literature DB >> 6777800

CSF GABA in psychotic disorders.

M B Bowers, B I Gold, R H Roth.   

Abstract

CSF GABA levels were not significantly different in a group of drug-free psychotic patients compared to a group of psychotic patients at two points during haloperidol treatment or a neurological comparison group. In the untreated group, CSF GABA was significantly negatively correlated with clinical ratings of anxiety and agitation. Early in haloperidol treatment CSF GABA was significantly positively correlated with CSF HVA.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777800     DOI: 10.1007/bf00427885

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  18 in total

1.  Cerebrospinal fluid gamma-aminobutyric acid: daily pattern and response to haloperidol.

Authors:  M J Perlow; S J Enna; P J O'Brien; H J Hoffman; R J Wyatt
Journal:  J Neurochem       Date:  1979-01       Impact factor: 5.372

2.  Effects of acute haloperidol on the gamma-aminobutyric acid system in rat striatum and substantia nigra.

Authors:  J S Kim; R Hassler
Journal:  Brain Res       Date:  1975-04-25       Impact factor: 3.252

3.  Letter: Gamma-aminobutyric acid in CSF in schizophrenia.

Authors:  D H Langer; G L Brown; W E Bunney; D P van Kammen
Journal:  N Engl J Med       Date:  1975-07-24       Impact factor: 91.245

Review 4.  Action of antischizophrenic drugs on the metabolism of gamma-aminobutyric acid and acetylcholine in globus pallidus, striatum and n. accumbens.

Authors:  E Costa; D L Cheney; C C Mao; F Moroni
Journal:  Fed Proc       Date:  1978-08

5.  Effect of chronic neuroleptic or L-DOPA administration on GABA levels in the rat substantia nigra.

Authors:  K G Lloyd; O Hornykiewics
Journal:  Life Sci       Date:  1977-11-15       Impact factor: 5.037

6.  Haloperidol and clazapine: specificity of action on GABA in the nigrostriatal system.

Authors:  A Maggi; F Cattabeni; F Bruno; G Racagni
Journal:  Brain Res       Date:  1977-09-16       Impact factor: 3.252

7.  GABA in plasma and cerebrospinal fluid of different species. Effects of gamma-acetylenic GABA, gamma-vinyl GABA and sodium valproate.

Authors:  W Löscher
Journal:  J Neurochem       Date:  1979-05       Impact factor: 5.372

8.  The relationship between GABA concentrations in brain and cerebrospinal fluid.

Authors:  P Böhlen; S Huot; M G Palfreyman
Journal:  Brain Res       Date:  1979-05-11       Impact factor: 3.252

9.  Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia.

Authors:  E Roberts
Journal:  Neurosci Res Program Bull       Date:  1972-11

10.  Premorbid asocial adjustment and prognosis in schizophrenia.

Authors:  R Gittelman-Klein; D F Klein
Journal:  J Psychiatr Res       Date:  1969-10       Impact factor: 4.791

View more
  3 in total

Review 1.  Glutamate, GABA, and CNS disease: a review.

Authors:  J E Walker
Journal:  Neurochem Res       Date:  1983-04       Impact factor: 3.996

Review 2.  Alterations of central GABAergic activity in neurologic and psychiatric disorders: evaluation through measurements of GABA and GAD activity in cerebrospinal fluid.

Authors:  T A Hare
Journal:  Mol Cell Biochem       Date:  1981-09-25       Impact factor: 3.396

3.  Low CSF GABA concentration in children with febrile convulsions, untreated epilepsy, and meningitis.

Authors:  D Rating; H Siemes; W Löscher
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.